AMAG Pharmaceuticals (AMAG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 01/30/20
AMAG Pharmaceuticals Awards Four Grants to Support Preterm Birth and Preeclampsia ResearchGlobeNewsWire • 12/18/19
Why Is AMAG Pharmaceuticals (AMAG) Up 9.7% Since Last Earnings Report?Zacks Investment Research • 12/01/19
Is the Options Market Predicting a Spike in AMAG Pharmaceuticals (AMAG) Stock?Zacks Investment Research • 11/26/19
AMAG Pharmaceuticals, Inc. (AMAG) CEO Bill Heiden on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/01/19
AMAG Pharmaceuticals' Q3 Results Overshadowed by Ominous FDA Panel RecommendationThe Motley Fool • 11/01/19
AMAG Pharmaceuticals (AMAG) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/01/19
Biotech Dives After Panel Votes To Pull Its Drug Following Faulty TestInvestors Business Daily • 10/30/19
AMAG Pharmaceuticals Falls 25% After FDA Recommends Removing Makena From The MarketBenzinga • 10/30/19
AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection)GlobeNewsWire • 10/30/19
AMAG Pharmaceuticals, Inc. (AMAG) Shares March Higher, Can It Continue?Zacks Investment Research • 10/29/19
AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG TrialGlobeNewsWire • 10/29/19
AMAG Pharmaceuticals (AMAG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/25/19
AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of PerinatologyGlobeNewsWire • 10/25/19
AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi™ (Bremelanotide Injection) Data in Obstetrics & GynecologyGlobeNewsWire • 10/11/19